Status:

WITHDRAWN

Effects of a Spine Navigation System on Op-time and Radiation Exposure

Lead Sponsor:

NYU Langone Health

Collaborating Sponsors:

7D Surgical Inc.

Conditions:

Spinal Stenosis

Scoliosis

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

The goal of this study is to prospectively collect information about the operative time and intraoperative radiation experienced by patients undergoing posterior spinal fusion procedures guided by the...

Detailed Description

This is a single-center, prospective case series to assess the use of the Machine-vision Image Guided Surgery (MvIGS) spine navigation system for treatment of spinal stenosis, scoliosis, and spondylol...

Eligibility Criteria

Inclusion

  • Diagnosis of spinal stenosis of the lumbar spine with degenerative spondylolisthesis, all grades, and planning to undergo surgical fusion;
  • Skeletally mature adults between the ages of 18-85 years at the time of surgery;
  • Has completed at least 6 months of conservative therapy for degenerative diagnosis, if appropriate; and,
  • Personally signed and dated an informed consent document prior to any study-related procedures, indicating that the patient has been informed of all pertinent aspects of the study.

Exclusion

  • History of malignancy, craniocervical junction pathology, cervical and thoracic locations, and/or previous lumbar operation;
  • Significant peripheral neuropathy or acute denervation secondary to radiculopathy, caused by conditions other than spinal stenosis;
  • Significant peripheral vascular disease (defined as diminished dorsalis pedis or tibial pulses);
  • Morbid obesity, defined as BMI \> 40 kg/m2;
  • Active systemic or local infection;
  • Active hepatitis (defined as receiving medical treatment within two years);
  • Immunocompromised, such as but not limited to being diagnosed with Acquired Immunodeficiency Syndrome (AIDS), HIV infection, Severe Combined Immunodeficiency Syndrome, or Thymic Hypoplasia;
  • Insulin-dependent diabetes mellitus or any other medical condition(s) that would represent a significant increase in surgical risk or interfere with normal healing;
  • Immunologically suppressed, or has received systemic steroids, excluding nasal steroids, at any dose daily for \> 1 month within last 12 months;
  • History of Paget's disease, osteomalacia, or any other metabolic bone disease;
  • Involved in study of another investigational product that may affect outcome;
  • Women who are pregnant, lactating or anticipate becoming pregnant within 24 months post-surgery;
  • Non-English speaking;
  • Patients who are incarcerated;
  • Worker's compensation cases; or,
  • Patients involved in active litigation relating to his/her spinal condition.

Key Trial Info

Start Date :

July 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2023

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04461964

Start Date

July 1 2022

End Date

June 1 2023

Last Update

June 13 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.